George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBushveld Minerals Regulatory News (BMN)

Share Price Information for Bushveld Minerals (BMN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.65
Bid: 0.60
Ask: 0.70
Change: 0.025 (4.00%)
Spread: 0.10 (16.667%)
Open: 0.625
High: 0.68
Low: 0.65
Prev. Close: 0.625
BMN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of AGM

2 Aug 2023 14:29

RNS Number : 1044I
Bushveld Minerals Limited
02 August 2023
 

2 August 2023

Bushveld Minerals Limited

("Bushveld Minerals", "Bushveld" or the "Company")

Annual General Meeting Results

 

Bushveld Minerals Limited (AIM: BMN), the AIM quoted, integrated primary vanadium producer and energy storage provider, with ownership of high-grade assets in South Africa, announces that all ordinary resolutions put to shareholders at the Annual General Meeting held earlier today were duly passed.

 

No.

ORDINARY RESOLUTIONS

VOTES

IN FAVOUR

AGAINST

WITHHELD

1

To receive and adopt the Annual Financial Statements of the Company and the Directors report and the report of the Auditors for the financial year ended 31 December 2022.

98 533 384

90 204

1 397 262

2

To approve the Directors' fees as reflected in the Remuneration Report and in note 35 of the Annual Financial Statements.

94 251 126

4 821 496

948 228

3

That Messrs RSM UK Audit LLP be reappointed as Auditors to the Company.

98 407 596

565 752

1 047 502

4

That the Directors be authorised to approve the remuneration of the Company's Auditors.

98 188 877

785 554

1 046 419

5

That Michael Kirkwood shall be re-elected as a Director, having retired by rotation and offered himself for re-election.

93 991 307

4 407 531

1 622 012

6

That Kevin Alcock shall be re-elected as a Director, having retired by rotation and offered himself for re-election.

96 996 430

1 402 408

1 622 012

7

That Craig Coltman shall be re-elected as a Director in accordance with Article 140 of the Articles, having been appointed by the Directors in July 2023.

97 963 133

1 036 196

1 021 521

8

The Company be generally and unconditionally authorised for the purposes of Articles 50.3 of the Articles to make on market acquisitions (as defined in Article 50.5 of the Articles) of ordinary shares on such terms and in such manner as the Directors determine provided that:

(i) the maximum aggregate number of ordinary shares which may be purchased is 128,781,828 ordinary shares;

(ii) the minimum price (excluding expenses) which may be paid for each ordinary share is £0.01;

(iii) the maximum price (excluding expenses) which may be paid for any ordinary share does not exceed 105 percent of the average closing

price of such shares for the five business days of AIM prior to the date of purchase; and

(iv) this authority shall expire at the conclusion of the next Annual General Meeting of the Company unless such authority is renewed prior to that time (except in relation the purchase of Ordinary Shares the contract for which was concluded before the expiry of such authority, in which case such purchase may be concluded wholly or partly after such expiry).

97 900 593

733 945

1 386 312

9

The Directors of the Company be and are hereby authorised to exercise all powers of the Company to issue, grant rights to subscribe for, or to convert any securities into, up to 429,272,760 shares (together "Equity Securities") in the capital of the Company being approximately one- third of the issued share capital of the Company (excluding treasury shares) in accordance with Article 8.3 of the Articles of Incorporation of the Company such authority to expire, unless previously renewed, revoked or varied by the Company by ordinary resolution, at the end of the next Annual General Meeting of the Company or, if earlier, at the close of business on the date falling 15 months from the date of the passing of this Resolution, but in each case, during this period the Company may make offers, and enter into agreements, which would, or might, require Equity Securities to be issued or granted after the authority given to the Directors of the Company pursuant to this

Resolution ends and the Directors of the Company may issue or grant Equity Securities under any such offer or agreement as if the authority given to the Directors of the Company pursuant to this Resolution had not ended. This Resolution is in substitution for all unexercised

authorities previously granted to the Directors of the Company to issue or grant Equity Securities; and

92 717 716

5 870 756

1 387 378

SPECIAL RESOLUTIONS

10

If Resolution 9 is passed, the Directors of the Company be and they are hereby authorised to exercise all powers of the Company to issue or grant Equity Securities in the capital of the Company pursuant to the issue or grant referred to in Resolution 9 as if the pre-emption rights contained in Article 9.9 of the Articles of Incorporation of the Company did not apply to such issue or grant provided that: (A) the maximum aggregate number of Equity Securities that may be issued or granted under this authority is 128,781,828 shares, being approximately 10.0 percent of the issued share capital of the Company (excluding treasury shares); and (B) the authority hereby conferred, unless previously renewed, revoked or varied by the Company by special resolution, shall expire at the end of the next Annual General Meeting of the Company or, if earlier, at the close of business on the date falling 15 months from the date of the passing of this Resolution, save that the Company may before such expiry make an offer or agreement which would or might require Equity Securities to be issued or granted after such expiry and the Directors may issue or grant Equity Securities in pursuance of such an offer or agreement as if the authority conferred by the above resolution had not expired. This Resolution is in substitution for all unexercised authorities previously granted to the Directors of the Company to issue or grant Equity Securities in the capital of the Company as if the pre-emption rights contained in Article 9.9 of the Articles of Incorporation of the Company did not apply to such issue or grant.

92 428 510

5 893 134

1 699 206

 

 

Enquiries: info@bushveldminerals.com

Bushveld Minerals Limited

+27 (0) 11 268 6555

Craig Coltman, Chief Executive Officer

Chika Edeh, Head of Investor Relations

SP Angel Corporate Finance LLP

Nominated Adviser & Broker

+44 (0) 20 3470 0470

Richard Morrison / Charlie Bouverat

 

Grant Baker / Richard Parlons

 

 

RBC Capital Markets

Joint Broker

+44 (0) 20 7653 4000

Jamil Miah / Sahil Suleman

 

 

Tavistock

Financial PR

Gareth Tredway / Tara Vivian-Neal/ James Whitaker

+44 (0) 207 920 3150

 

 

ABOUT BUSHVELD MINERALS LIMITED

Bushveld Minerals is a low-cost, vertically integrated primary vanadium producer. It is one of only three operating primary vanadium producers, owning 2 of the world's 4 operating primary vanadium processing facilities. In 2022, the Company produced more than 3,800 mtV, representing approximately three per cent of the global vanadium market. With a diversified vanadium product portfolio serving the needs of the steel, energy and chemical sectors, the Company participates in the entire vanadium value chain through its two main pillars: Bushveld Vanadium, which mines and processes vanadium ore; and Bushveld Energy, an energy storage solutions provider.

Bushveld Energy is focused on developing and promoting the role of vanadium in the growing global energy storage market through the advancement of vanadium-based energy storage systems, specifically Vanadium Redox Flow Batteries ("VRFBs").

 

Detailed information on the Company and progress to date can be accessed on the website www.bushveldminerals.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGSSEFDEEDSEEA
Date   Source Headline
23rd Apr 20247:01 amRNSQ1 2024 Operational & Corporate Update
23rd Apr 20247:00 amRNSMineral Resources and Reserves Annual Update
14th Mar 20249:32 amRNSFurther Update on Outstanding Funds
14th Mar 20247:00 amRNSTR-1 Notification of Major Holdings
7th Mar 20243:00 pmRNSTR-1 Notification of Major Holdings
29th Feb 20245:30 pmRNSFurther Update on Outstanding Funds
16th Feb 20247:08 amRNSFurther update on Outstanding Funds
5th Feb 20247:08 amRNSFull year 2023 Operational Update
2nd Feb 20242:30 pmRNSForm 8.3 of the Takeover Code
1st Feb 20247:00 amRNSCompletion of Convertible Loan Note Refinancing
29th Jan 20244:25 pmRNSResignation of Finance Director
19th Jan 20244:32 pmRNSFurther Update on Outstanding Funds
15th Jan 20245:25 pmRNSTR-1 Notification of Major Holdings
15th Jan 20245:23 pmRNSTR-1 Notification of Major Holdings
15th Jan 202411:12 amRNSFurther update on Outstanding Funds
10th Jan 202412:55 pmRNSUpdate on Outstanding Funds
3rd Jan 20242:30 pmRNSUpdate following Equity Issue
27th Dec 20232:30 pmRNSResult of General Meeting
21st Dec 20237:00 amRNSReminder to vote at the General Meeting
19th Dec 202311:24 amRNSConfirmed Acquisition of Interests in Vametco
19th Dec 20237:32 amRNSConfirmed Acquisition of Interests in Vametco
15th Dec 20237:52 amRNSDefinitive sales and marketing agreement with SPR
15th Dec 20237:51 amRNSDefinitive agreement for 64% Mokopane Sale
14th Dec 202311:07 amRNSOption Agreement with Portillion
13th Dec 20237:00 amRNSCorporate Update
12th Dec 20237:00 amRNSResults of PrimaryBid Offer
6th Dec 202312:00 pmRNSInvestor Presentation
5th Dec 20231:00 pmRNSPrimaryBid Offer
5th Dec 202312:51 pmRNSResult of Bookbuild
29th Nov 20233:35 pmRNSProposed Fundraising
27th Nov 20237:00 amRNSAgreement on Convertible Loan Note Refinancing
20th Nov 202310:20 amRNSBushveld Energy Update
20th Nov 20237:15 amRNSAgreement for acquisition of interest in Vanchem
16th Nov 20235:32 pmRNSResignation of Finance Director
6th Nov 20237:00 amRNSQ3 2023 and 9M 2023 Operational Update
30th Oct 20237:00 amRNSConditional acquisition of interests in Vametco
18th Oct 20237:00 amRNSHolding(s) in Company
10th Oct 20237:00 amRNSResponse to Market Speculation
26th Sep 20237:00 amRNSInterim Results for Six Months ended 30 June 2023
20th Sep 20234:45 pmRNSHolding(s) in Company
11th Sep 20237:00 amRNSInvestment by Southern Point Resources
1st Sep 20233:58 pmRNSTR-1: Standard Notification of Major Holdings
21st Aug 20236:00 pmRNSTR-1: Standard Notification of Major Holdings
9th Aug 20231:00 pmRNSMustang Energy Update: Conversion Notice
3rd Aug 20234:39 pmRNSHolding(s) in Company
2nd Aug 20232:29 pmRNSResult of AGM
2nd Aug 20237:00 amRNSQ2 and H1 2023 Operational Update
28th Jul 20237:00 amRNSEnerox Update
14th Jul 20233:58 pmRNSConvertible Loan Note Update
6th Jul 20239:00 amRNSREPLACEMENT: Posting of Accounts and Notice of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.